Study compares patch test positivity: 24 versus 48 hours of occlusion time in allergic contact dermatitis patients
India: A recent prospective study published in Contact Dermatitis compared patch test positivity after 24 and 48 hours of occlusion time in patients with allergic contact dermatitis (ACD).
The researchers reported no significant difference in patch test among ISS allergens after either occlusion time, 48 h occlusion performed significantly better versus 24 h when reactions of all allergens (ISS, parthenium acetone extract, and patient material) are analyzed together.
Allergic contact dermatitis is a common skin disorder characterized by inflammation resulting from exposure to allergens. Patch testing is a valuable diagnostic tool used to identify the culprit allergens. However, the duration of occlusion during patch testing remains a subject of debate among dermatologists.
Conventionally, the patches are applied for 48 hours, which causes excessive sweating in tropical weather conditions, leading to irritation, and sometimes the patches come off, making the test inconclusive. In a recent study, Kaushal Verma, Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India, and colleagues sought to compare the patch test positivity after 24 and 48 h of occlusion time in patients of allergic contact dermatitis, using standard allergen concentration.
The study involved clinically suspected allergic contact dermatitis patients and patch-tested using the Indian Standard Series, parthenium acetone extracts (1:50, 1:100, and 1:200 dilutions), and patient material. Using a random number table, patches were applied in duplicate on either side of the back.
One set of patches was removed following 24-h occlusion, while the other set after 48-h. Two independent dermatologists performed the readings at 48- and 96-h, blinder to the duration of occlusion.
The study revealed the following findings:
- 133 and 142 positive reactions were observed after 48 h occlusion at 48 and 96 h reading, respectively. Of these 87.9% and 92.9% patches were positive and concordant and noted at 24 h occlusion time.
- The Cohen's kappa coefficient was 0.94 for 48 h and 0.97 for 96 h reading, showing an almost complete agreement (ⱪ > 0.81) between patches occluded for 24 and 48 h.
"A 24-hour occlusion period may be sufficient for some patch test series (such as the ISS); however, other patch series with different allergens require further assessment with this shorter occlusion time," the researchers wrote.
The implications of these findings are significant for ACD management. By optimizing patch testing protocols, clinicians can enhance diagnostic accuracy, leading to more precise identification of allergens and better management of the condition. This, in turn, facilitates the development of personalized treatment plans tailored to each patient's specific sensitivities.
In conclusion, the comparative analysis of patch test positivity after 24 and 48 hours of occlusion time offers valuable insights into optimizing diagnostic approaches for allergic contact dermatitis.
By considering individual variations in occlusion duration and allergen reactivity, dermatologists can improve the accuracy of patch testing and enhance patient care in managing this common dermatological condition.
Reference:
Ahuja, R., Bhari, N., Sethuraman, G., Kalaivani, M., & Verma, K. Comparison of patch test positivity after 24 and 48 hours of occlusion time in patients of allergic contact dermatitis: A prospective study. Contact Dermatitis. https://doi.org/10.1111/cod.14543
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.